Related Experiment Video
Updated: Aug 23, 2025

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
Published on: February 3, 2021
Level of Vascular Inflammation Is Higher in Acute Coronary Syndromes Compared with Chronic Coronary Disease
Makoto Araki1, Tomoyo Sugiyama2, Akihiro Nakajima1
1Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA (M.A., A.N., L.M.S., I.M., I.-K.J.).
Insights
Higher pericoronary adipose tissue (PCAT) attenuation indicates coronary artery inflammation in acute coronary syndromes (ACS) patients compared to stable angina (SAP). PCAT attenuation is a key marker for vascular inflammation in ACS pathogenesis.
Area of Science:
- Cardiology
- Radiology
- Inflammation Research
Background:
- Vascular inflammation is central to acute coronary syndromes (ACS) pathogenesis.
- Pericoronary adipose tissue (PCAT) attenuation on CT angiography signifies coronary artery inflammation.
- PCAT attenuation may correlate with clinical presentation and plaque characteristics.
Purpose of the Study:
- To investigate the relationship between clinical presentation (ACS vs. SAP) and coronary artery inflammation.
- To assess coronary artery inflammation using PCAT attenuation measured by CT angiography.
- To correlate PCAT attenuation with coronary plaque characteristics.
Main Methods:
- Patients with ACS or stable angina pectoris (SAP) undergoing coronary CT angiography and OCT were enrolled.
- PCAT attenuation was quantified around culprit lesions and in proximal coronary arteries.
- PCAT findings were compared between ACS and SAP groups.
Main Results:
- PCAT attenuation was significantly higher in ACS patients versus SAP patients at culprit plaque, culprit vessel, and pan-coronary levels.
- Higher PCAT attenuation was independently associated with ACS presentation, alongside thin-cap fibroatheroma and macrophages.
- These findings suggest PCAT attenuation is a marker for inflammation in ACS.
Conclusions:
- PCAT attenuation is elevated in ACS patients, indicating increased vascular inflammation.
- PCAT attenuation serves as a valuable imaging biomarker for identifying coronary artery inflammation in ACS.
- Vascular inflammation, as indicated by PCAT attenuation, plays a critical role in ACS development.
Background:
Vascular inflammation has been recognized as one of the key factors in the pathogenesis of acute coronary syndromes (ACS). Pericoronary adipose tissue (PCAT) attenuation by computed tomography angiography has emerged as a marker specific for coronary artery inflammation. We examined the relationship between clinical presentation and coronary artery inflammation assessed by PCAT attenuation and coronary plaque characteristics.
Methods:
Patients with ACS or stable angina pectoris (SAP) who underwent preintervention coronary computed tomography angiography and optical coherence tomography were enrolled. PCAT attenuation was measured around the culprit lesion and in the proximal 40 mm of all coronary arteries. PCAT attenuation and optical coherence tomography findings were compared between patients with ACS versus SAP.
Results:
Among 471 patients (ACS: 198, SAP: 273), PCAT attenuation was higher in ACS patients than in SAP patients both at the culprit plaque level (-67.5±9.6 Hounsfield unit [HU] versus -71.5±11.0 HU, P<0.001) and at the culprit vessel level (-68.3±7.7 HU versus -71.1±7.9 HU, P<0.001). The mean PCAT attenuation of all 3 coronary arteries was also significantly higher in ACS patients than in SAP patients (-68.8±6.3 HU versus -70.5±7.1 HU, P=0.007). After adjusting patient characteristics, not only thin-cap fibroatheroma (OR: 3.41; 95% CI: 1.89-6.17) and macrophages (OR: 3.32; 95% CI: 1.76-6.26) but also PCAT attenuation around the culprit plaque (OR: 1.03; 95% CI: 1.00-1.05) was associated with the clinical presentation of ACS.
Conclusions:
PCAT attenuation at culprit plaque, culprit vessel, and pan-coronary levels was higher in ACS patients than in SAP patients. Vascular inflammation appears to play a crucial role in the development of ACS.
Registration:
URL: https://www.
Clinicaltrials:
gov; Unique identifier: NCT04523194.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome I: Introduction
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome V: Nursing Management
Coronary Artery Disease II: Pathophysiology

